Cosciens Biopharma Inc
(CSCIF)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -17,187 | -27,240 | -20,410 | -27,060 | -23,210 |
| Depreciation Amortization | 878 | -5,097 | 1,190 | 2,870 | 1,590 |
| Accounts receivable | -578 | -3 | N/A | N/A | N/A |
| Other Working Capital | -1,873 | -7,990 | -7,590 | 4,200 | -7,680 |
| Other Operating Activity | -12,322 | 20,346 | -4,000 | -6,250 | -1,820 |
| Operating Cash Flow | $-31,082 | $-19,984 | $-30,810 | $-26,240 | $-31,120 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -61 | -85 | -270 | -710 | -50 |
| Other Investing Activity | 0 | 113 | 0 | 3,170 | 0 |
| Investing Cash Flow | $-61 | $28 | $-270 | $2,460 | $-50 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 24,358 | 23,708 | N/A | N/A | N/A |
| Other Financing Activity | 0 | 0 | 24,200 | 38,550 | 25,430 |
| Financing Cash Flow | $24,358 | $23,708 | $24,200 | $38,550 | $25,430 |
| Exchange Rate Effect | -1,486 | -71 | -480 | 100 | -360 |
| Beginning Cash Position | 43,202 | 39,521 | 46,880 | 31,990 | 38,100 |
| End Cash Position | 34,931 | 43,202 | 39,520 | 46,880 | 31,990 |
| Net Cash Flow | $-8,271 | $3,681 | $-7,360 | $14,880 | $-6,100 |
| Free Cash Flow | |||||
| Operating Cash Flow | -31,082 | -19,984 | -30,810 | -26,240 | -31,120 |
| Capital Expenditure | -127 | -85 | N/A | N/A | N/A |
| Free Cash Flow | -31,209 | -20,069 | -30,810 | -26,240 | -31,120 |